Idera Pharmaceuticals (IDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | IDRA | AZN | AMGN | GILD | VRTX |
| Company | Idera Pharmaceuticals | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.4800 | 206.60 | 372.01 | 150.58 | 466.94 |
| High | 0.5100 | 207.69 | 377.00 | 153.26 | 479.12 |
| Low | 0.4200 | 204.05 | 371.39 | 150.09 | 465.00 |
| Latest | 0.4250 | 204.20 | 374.75 | 151.40 | 476.90 |
| Change | -0.1169 | -2.25 | -0.75 | +0.28 | +7.63 |
| % Change | -21.57% | -1.09% | -0.20% | +0.19% | +1.63% |
| Volume | 371,800 | 1,592,600 | 2,911,700 | 6,986,900 | 1,006,600 |
| 20-Day Average Volume | 308,970 | 2,907,065 | 3,021,635 | 8,419,010 | 1,546,910 |
| Previous Close | 0.5419 | 206.45 | 375.50 | 151.12 | 469.27 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.4095 | 194.51 | 361.01 | 147.11 | 471.68 |
| 20-Day Raw Stochastic | 41.58% | 71.47% | 77.96% | 77.60% | 45.48% |
| 20-Day Relative Strength | 51.01 | 61.52 | 62.17 | 63.79 | 54.68 |
| Weighted Alpha | -72.05 | +46.18 | +32.38 | +48.00 | +5.16 |
| Today's Opinion | 8% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 100% Sell | 64% Buy | 88% Buy | 96% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -35.11% since 01/09/23 | -0.16% since 02/12/26 | +2.33% since 02/12/26 | -0.27% since 02/12/26 | +2.55% since 02/12/26 |
| Low | 0.4200 on 01/17/23 | 204.05 on 02/20/26 | 361.71 on 02/13/26 | 150.09 on 02/20/26 | 463.00 on 02/19/26 |
| High | 0.7000 on 01/10/23 | 212.71 on 02/18/26 | 380.58 on 02/18/26 | 156.95 on 02/13/26 | 503.88 on 02/13/26 |
| 1-Month | |||||
| %Chg | +57.41% since 12/16/22 | +13.52% since 01/20/26 | +13.22% since 01/20/26 | +21.96% since 01/20/26 | +7.88% since 01/20/26 |
| Low | 0.2150 on 12/28/22 | 178.08 on 01/21/26 | 329.32 on 01/21/26 | 122.68 on 01/21/26 | 439.91 on 01/21/26 |
| High | 0.7200 on 01/06/23 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | +20.81% since 10/17/22 | +15.13% since 11/20/25 | +11.51% since 11/20/25 | +21.13% since 11/20/25 | +12.92% since 11/20/25 |
| Low | 0.2150 on 12/28/22 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 421.87 on 11/21/25 |
| High | 0.7200 on 01/06/23 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | -1.46% since 07/15/22 | +26.80% since 08/20/25 | +26.41% since 08/20/25 | +27.52% since 08/20/25 | +20.93% since 08/20/25 |
| Low | 0.2150 on 12/28/22 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 0.7200 on 01/06/23 | 212.71 on 02/18/26 | 385.12 on 02/06/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 26,501 | 316,695,392 | 202,015,744 | 187,838,960 | 121,148,808 |
| Shares Outstanding, K | 62,355 | 1,550,908 | 539,068 | 1,240,680 | 254,034 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 98,090,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 50,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -3,100,000 | 2,326,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.25 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 11/14/22 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 03/30/23 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 02/13/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.76 | 17.19 | 18.54 | 28.58 |